Bristol-Myers Squibb Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (64)

Latest Posts

About This Stock More About This Stock
Healthcare Investing Ideas Big And Small
Article By: Marc Lichtenfeld
Monday, January 15, 2018 9:00 PM EST
With a dire need for growth, many in the industry expect the larger biotech and pharmaceutical companies to open their wallets and acquire smaller companies with novel drugs in development.
In this article: BMY, GSK, JNJ, PFE, AVXL, IMMP, BMRN, FOLD, SGEN, MBOT
Read
Week In Review: Hua Medicine To Raise $200 Million Through Fundings And IPO For Oral Diabetes Drug
Article By: ChinaBio® Today
Saturday, January 13, 2018 6:23 PM EST
Hua Medicine of Shanghai expects to spend $200 million over the next three years on its novel oral diabetes 2 treatment, dorzagliatin. The company will raise additional capital for the effort and then IPO, possibly in Hong Kong or the US.
In this article: VRACY, BSTG, VAR, AZN, BMY, AMGN, BGNE
Read
Pharma Stock Roundup: Roche, MNK Announce Acquisition Agreements, Regulatory Updates From Novartis
Article By: Arpita Dutt
Saturday, December 30, 2017 7:49 PM EST
Key announcements in the pharma space this week include a couple of acquisition announcements and regulatory updates from Novartis.
In this article: AGN, AZN, BMY, GSK, NVS, RHHBY, MNK
Read
Biotech Year One: A Year Of Trials Tribulations And Discovery
Article By: Kieran O'Dea
Monday, December 25, 2017 8:24 AM EST
The biotech market is its own beast, derived from the aggregate opinions and knowledge of the mainstream thought. The market has a binary, linear, and simplistic approach to trial results ignoring the context in which each trial is conducted.
In this article: IBB, XBI, XPH, SPY, TEVA, AGN, JNJ, MYL, BMY, BIIB, PFE, MRK, INCY
Read
Week In Review: China Life Science Deals Total $550 Million
Article By: ChinaBio® Today
Saturday, December 9, 2017 4:13 PM EST
Pfizer (NYSE: PFE​) signed a $226 million agreement for China/Asian rights to Cresemba® (isavuconazole), an antifungal drug and Everest Medicines announced a $224 million partnership with San Diego's Arena Pharma.
In this article: JNJ, GNBT, BYSI, BMY, ARNA, BABA, PFE
Read

PARTNER HEADLINES

Latest Tweets for $BMY

No tweets yet!

$BMY

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 1 of 1 comments